Atea Pharmaceuticals, Inc. (AVIR) › Net IncomeAtea Pharmaceuticals, Inc. (AVIR) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$9.06M2019: -$14.03M2020: -$10.95M2021: $121.19M2022: -$115.91M2023: -$135.96M2024: -$168.38M2025: -$158.35M-$158.35M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$158.35M+6.0%2024-$168.38M-23.9%2023-$135.96M-17.3%2022-$115.91M-195.6%2021$121.19M+1207.1%2020-$10.95M+22.0%2019-$14.03M-54.8%2018-$9.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share